title: Reversible neutropenia and thrombocytopenia during famotidine treatment.
authors.forename: O
authors.initials: O
authors.lastname: Oymak
authors.forename: T
authors.initials: T
authors.lastname: Akpolat
authors.forename: N
authors.initials: N
authors.lastname: Arik
authors.forename: U
authors.initials: U
authors.lastname: Yasavul
authors.forename: C
authors.initials: C
authors.lastname: Turgan
authors.forename: S
authors.initials: S
authors.lastname: Caglar
mesh_terms: D015738:Famotidine / Q000009:adverse effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D015738:Famotidine